

Interview with Science 37 CEO David Coman
Sep 8, 2022
31:28
Science 37 is a publicly traded pioneer in decentralized clinical trials, which offers an end-to-end 'operating' system for trial sponsors and CROs. The company leverages its various networks to enable hybrid and fully decentralized trials. The decentralized model also helps foster diversity and inclusion, which has become an important selling point.
As of March 2025 HealthBiz is part of CareTalk. Healthcare. Unfiltered and can be found at the following links:
- Spotify https://open.spotify.com/show/2GTYhbNnvDHriDp7Xo9s6Z
- Apple https://podcasts.apple.com/us/podcast/caretalk-healthcare-unfiltered/id1532402352
- YouTube https://www.youtube.com/@CareTalkPodcast
- CareTalk website https://www.caretalkpodcast.com/
Host David E. Williams is president of healthcare strategy consulting firm Health Business Group.
Episodes through March 2025 were produced by Dafna Williams.